To work on the development of innovative therapeutic agents for the treatment of communicable and non-communicable diseases
To work on the development of innovative therapeutic agents for the treatment of communicable and non-communicable diseases
XRNA Therapeutics Ltd, a start-up incubating at Aspire BioNest, on Friday signed agreements with two faculty members from the School of Life Sciences at the University of Hyderabad (UoH) for joint collaborative research.
The start-up is working on the development of new therapeutic agents to treat communicable and non-communicable diseases. Professor Sharmistha Banerjee and Nooruddin Khan, participating faculty members in this field, will investigate and validate novel molecules developed by XRNA Therapeutics for better treatment of viral and bacterial infections, either alone or in combination, a press release said. In.
The agreements were signed by Director R&D GS Prasad and XRNA Therapeutics CMD Vinay Tiwari on behalf of the participating faculty, and exchanged in the presence of UOH VC BJ Rao and Registrar Devesh Nigam.
“A supportive and nurturing innovation ecosystem in an academic institution is extremely beneficial not only to the institution but also to the students and faculty. UoH and ASPIRE have become role models which are being replicated across many academic institutions as it is a part of academics. Helps translate research results into technologies and products,” said the VC.
Rajagopal, Director and Coordinator of Aspire and Aspire BioNest, and Professor of the School of Life Sciences, said, “Aspire BioNest encourages all its start-ups to collaborate with the faculty of the university because of their experience in basic and applied science start-ups. will help up. To take their technologies to market faster”.
“Aspire through its incubation centers at UoH, Aspire BioNest, Aspire-TBI and Aspire Tide, supports start-ups arising from life sciences, pharma, chemistry, IT and electronics respectively. Presently, our activities are spread over 53,000 square feet and we are planning to expand further. The three incubation centers together supported around 80 start-ups, of which 30 have successfully graduated and are currently operating with full occupancy,” said Mr. Prasad.